ASX Reporting Season wrap: CBA, DMP, TWE, MFG, BHP and CSL
Lachlan Buur-Jensen
August 20, 2021
What a week of ASX Reporting Season! The results are
CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
What a week of ASX Reporting Season! The results are
The S&P/ASX 200 (ASX: XJO) fell 0.1% on Wednesday solely
Australia’s third-largest public company CSL Limited (ASX: CSL) achieved steady
The S&P/ASX 200 (ASX:XJO) finished at another record high on
The S&P/ASX 200 (ASX: XJO) charged 2% higher for the
The S&P/ASX 200 (ASX: XJO) managed to deliver another positive
Growing global outbreaks of the Delta strain have shaken markets
The S&P/ASX 200 (ASX:XJO) strengthened throughout the day to finish
The S&P/ASX 200 (ASX: XJO) managed a 0.2% gain on
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
Here you go: A $50,000 per year passive income special report
Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.
Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.
Unsubscribe anytime. Read our Terms, Financial Services Guide, Privacy Policy. We’ll never sell your email address. Our company is Australian owned.